Who we are

Nichepharm Lifesciences Private Limited is a contract development and manufacturing organization (CDMO) specializing in small volume parenterals. Our mission is to develop innovative, niche injectables cost-effectively to improve and extend patient lives. With high-quality, best-in-class offerings, we meet the growing demand for sterile injectables and biologics in regulated markets while providing affordable medicines for India and beyond.

Led by promoters with over 30 years of experience, we are a trusted partner for top pharmaceutical companies, focusing on complex dosages with technical expertise and unwavering quality. Nichepharm is headquartered in Gurgaon, Haryana, and operates a state-of-the-art manufacturing facility in Selaqui, Dehradun.

Our facility is designed to be compliant with all international regulatory authorities and has the capability to manufacture a wide range of small volume parenterals. With the capacity to produce up to one billion units annually, Nichepharm offers one of the largest production capabilities in India's injectable sector.

People power everything we do.

From experienced leadership to skilled operators, every member of the Nichepharm team plays a role in delivering safe, effective medicines — with care, pride, and precision.

Meet the team

Founders

Our vision is shaped by experience and driven by purpose.

Late Sh MM Sobti

Late Sh MM Sobti

Founder

Nichepharm was founded on Mr MM Sobti’s belief that Indian manufacturing could meet the highest global standards. Over three decades on, that conviction still guides every product we make and every partnership we build.

Dr Chetan Sobti

Dr Chetan Sobti

Director

Trust has been the foundation of Nichepharm since its founding and remains its greatest commercial strength. As the company expands into new markets worldwide, every partner receives the reliability and quality that have defined us for over three decades.

Mr Nitin Sobti

Mr. Nitin Sobti

Director

Nichepharm’s facility is built to the highest global standards, optimised for efficiency and consistent across every product. As we expand this scale through continued investment in people and technology, we grow with the precision that underpins the confidence our customers place in us.

Leadership

Guided by sterile pharmaceutical excellence and technical operational execution.

Ajay Nautyal

Ajay Nautyal

Vice President Quality

""With a legacy of quality spanning three decades, we at Nichepharm embody a culture of 'zero defect products' that consistently exceeds the most stringent regulatory and customer requirements."

Avijit Lahiri

Avijit Lahiri

Vice President Operations

“Built on operational excellence and experience with leading pharmaceutical companies, we are committed to delivering reliable, scalable solutions for even the most complex formulations.”

Sanchit Gupta

Sanchit Gupta

Head Supply Chain & Procurement

“Through resilient sourcing and optimised logistics, Nichepharm ensures on-time delivery for clients across markets. Our secure procurement paths protect continuity of supply, so our partners can grow with confidence.”

Rahul Wadhwa

Rahul Wadhwa

Head Business Development & Projects

“Developing strategic global partnerships lies at the core of Nichepharm’s growth. We offer flexible manufacturing across multiple sterile dosage forms, aimed at turning each partnership into a lasting, productive collaboration.”

Our Story

A legacy of innovation, trust, and sterile manufacturing excellence spanning three decades.

1995 – 2011
2014 – 2019
2021 – Today
1995 01

Humble Beginnings

Under the visionary leadership of Mr. M.M. Sobti, a pioneering dairy technologist, the Sobti family laid the foundation of Nitin Pharmaceuticals Private Limited in Karnal, planting the seeds of a legacy in injectable manufacturing.

1995 Karnal
2005 02

A Strategic Leap

Capitalising on progressive reforms, the Sobti family established Nitin Lifesciences Ltd. in Paonta Sahib, Himachal Pradesh. With a focus on sterile injectables, it rapidly rose to prominence.

2005 Paonta Sahib
2011 03

Consolidation

In a strategic move to unify operations and scale capabilities, Nitin Pharmaceuticals (Karnal) merged with Nitin Lifesciences (Paonta Sahib), creating a robust consolidated entity. Added new facilities for cephalosporins at Paonta and Beta Lactams at Karnal.

2011 Merger
2014 04

World-class facility & Lyophilisation

Nitin Lifesciences Limited set up a new sterile manufacturing site in Paonta Sahib, expanding our offerings to include lyophilized products and deepening reach across global markets.

2014 Lyophilised
2016 05

Global Collaboration

The Sobti family forged a strategic partnership with global CDMO leader Recipharm, which acquired a 74% stake. Core leadership remained integral to operations to ensure continuity.

2016 Recipharm Partnership
2018 06

Growth with continuity

The facilities were further upgraded to meet international regulatory requirements. The Sobti family divested their remaining stake in Nitin Lifesciences but continued to oversee operations, reinforcing their deep-rooted commitment to maintaining customer trust. Land was acquired for their new greenfield project, Nichepharm, starting the next chapter of this journey.

2018 development site
2019 07

Birth of Nichepharm

Sobti family laid the foundation for Nichepharm, a next-generation sterile manufacturing site in Selaqui, Dehradun. Reaffirming the legacy, Recipharm came forward to join hands at inception as a minority (8%) stakeholder.

2019 Nichepharm
2021 08

Ready for the Future

Our world-class facility started commercial production.WHO GMP accreditation was achieved. Recipharm increased its stake to 24%, underscoring trust. The facility quickly became a benchmark in manufacturing excellence.

2021 Operational
2023 09

Renewed Focus

With a clear vision for the future, the Sobti family transitioned out of Nitin Lifesciences to fully dedicate their expertise and leadership to Nichepharm. Added pre-filled syringes and cartridges capacity to the Nichepharm site.

2023 Full Focus
2024 10

100% Ownership Restored

With a forward-looking strategy, the Sobti family bought back Recipharm’s stake, regaining complete ownership of Nichepharm. Our mission: to lead with agility, innovation, and customer-centricity.

2024 Buyback
Today 11

Global Partner

Nichepharm is now the preferred partner for leading MNCs and top Indian pharma companies. We are expanding our footprint across international markets, with accreditations from various ROW authorities.Embarking now on a new journey for SRA approvals including ANVISA Brazil, CIS, and EMA.

Today Partner

Let our experts offer you a better solution

Share your details and embark on your CDMO journey with us

Contact Us